Verrica Pharmaceuticals Overview
- Founded
- 2013
- Status
- Public
- Employees
- 17
- Stock Symbol
- VRCA
- Share Price
- $11.76
- (As of Wednesday Closing)
Verrica Pharmaceuticals General Information
Description
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
- Durham, NC
- United States
+1 (610) 000-0000
Verrica Pharmaceuticals Stock Performance
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $11.76 | $11.12 | $6.02 - $17.60 | $304M | 25.9M | 69.2K | -$1.50 |
Verrica Pharmaceuticals Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 155,026 | 338,707 | 112,450 | |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (35,889) | (29,827) | (21,859) | (4,457) |
| Net Income | (37,354) | (28,207) | (20,648) | (4,459) |
| Total Assets | 79,936 | 68,424 | 91,906 | 9,083 |
| Total Debt | 36,976 | 188 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Verrica Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Verrica Pharmaceuticals‘s full profile, request access.
Request a free trialVerrica Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is available in the PitchBook Platform. To explore Verrica Pharmaceuticals‘s full profile, request access.
Request a free trialVerrica Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of no
Drug Discovery
Durham, NC
17
As of 2019
00000
000000 - 000
00000
0000000
ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labori
000000000000000
Wayne, PA
00
As of 0000
00000
00000000000
00000
00000000
ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
000000000000000
Houston, TX
00
As of 0000
000.00
000000000
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialVerrica Pharmaceuticals Competitors (8)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aclaris Therapeutics | Formerly VC-backed | Wayne, PA | 00 | 00000 | 00000000000 | 00000 |
| 000000000 | Formerly PE-Backed | Houston, TX | 00 | 000.00 | 000000000 | 000.00 |
| 00000000 000000000 | Private Debt Financed | San Diego, CA | 00 | 000000000 - | ||
| 0000 0000000000000 | Formerly PE-Backed | West Chester, PA | 000000&0 | |||
| 000000 | Formerly PE-Backed | Newport Beach, CA | 000 | 00000 | 00000000 | 00000 |
Verrica Pharmaceuticals Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Ted White | Chief Executive Officer & Board Member | ||
| Matthew Davidson Ph.D | Founder, Chief Scientific Officer & Board Member | ||
| Patrick Burnett Ph.D | Chief Medical Officer |
Verrica Pharmaceuticals Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| Lawrence Eichenfield MD | Self | Board Member | 000 0000 |
| Matthew Davidson Ph.D | Verrica Pharmaceuticals | Founder, Chief Scientific Officer & Board Member | 000 0000 |
| Paul Manning | PBM Capital Group | Chairman & Board Member | 000 0000 |
| Sean Stalfort | Verrica Pharmaceuticals | Board Member | 000 0000 |
| Ted White | Verrica Pharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
Verrica Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialVerrica Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Verrica Pharmaceuticals‘s full profile, request access.
Request a free trial